This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Cerebral 18F-FDG PET/CT Metabolism as Diagnostic Signature for Central Nervous System Toxicity After Immune Checkpoint Blockade Cancer Treatment
- At Last, 18F-FDG for Inflammation and Infection!
- Role of 18F-fluoro-2-deoxyglucose positronemission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up
- Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review
- Quantitative Immuno-Positron Emission Tomography Imaging of HER2-Positive Tumor Xenografts with an Iodine-124 Labeled Anti-HER2 Diabody
- Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment
- In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography
- 18F-FDG Accumulation with PET for Differentiation Between Benign and Malignant Lesions in the Thorax
- 18F-Fluorocholine: A New Oncologic PET Tracer
- Comparison of [18F]FDG PET and 201Tl SPECT in Evaluation of Pulmonary Nodules